Page last updated: 2024-11-03

probenecid and Biliary Tract Diseases

probenecid has been researched along with Biliary Tract Diseases in 2 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Biliary Tract Diseases: Diseases in any part of the BILIARY TRACT including the BILE DUCTS and the GALLBLADDER.

Research Excerpts

ExcerptRelevanceReference
"Cephalexin was given to 24 patients before and after operation on the bile ducts and gall bladder."1.25Cephalexin levels in human bile in presence of biliary tract disease. ( O'Grady, F; Sales, JE; Sutcliffe, M, 1972)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Legler, F1
Sales, JE1
Sutcliffe, M1
O'Grady, F1

Other Studies

2 other studies available for probenecid and Biliary Tract Diseases

ArticleYear
[The role of ampicillin in antibiotic therapy with special reference to laboratory findings].
    Arzneimittel-Forschung, 1966, Volume: 16, Issue:7

    Topics: Ampicillin; Biliary Tract Diseases; Escherichia coli Infections; Humans; Klebsiella Infections; Meni

1966
Cephalexin levels in human bile in presence of biliary tract disease.
    British medical journal, 1972, Aug-19, Volume: 3, Issue:5824

    Topics: Bile; Bile Ducts; Biliary Tract Diseases; Carrier State; Cephalexin; Cholestasis; Gallbladder; Human

1972